National Association of Testing Authorities, Australia
Scope of Accreditation
Victorian Infectious Diseases Reference Laboratory
Site
Victorian Infectious Diseases Reference Laboratory
Accreditation No.
2576
Site No.
2569
Date of Accreditation
08 Mar 1989
Contact
Ms Eve (Li) Dong P: +61 (03) 93429644
Availability
Services available to external clients
Supervision
GX (General)
Scope of Accreditation
Bacteriology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
31 Oct 2026
Last Activity Date
10 May 2023
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Aspirates; Biopsy specimens; Bronchoalveolar lavage; Bronchoalveolar washings; Fluids; Respiratory specimens; Sputum; Tissues | Legionella pneumophila; Cultured pathogens identification |
| Bacterial isolates | Cultured pathogens identification | |
| Blood | Bacteria | |
| Cervical swabs; Genital swabs; Rectal swabs; Urethra; Vaginal swabs | Pathogenic identification and antibiotic susceptibility | |
| Ear swabs; Eye swabs; Nasal swabs; Throat swabs | Antibiotic susceptibility; Cultured pathogens identification | |
| Faeces | Clostridioides difficile toxin | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Anal swab; Cervical swabs; Genital swabs; Rectal swabs; Urethral swabs; Urine; Vaginal swabs | Chlamydia trachomatis serovars L1, L2, L2a or L3 (LGV) |
| Aspirates; Cerebrospinal fluid (CSF); Eye swabs; Fluids; Genital swabs; Meatal swabs; Plasma; Rectal swabs; Serum; Throat swabs; Tissues; Urethral swabs; Urine | Chlamydia trachomatis; Mycoplasma genitalium; Neisseria gonorrhoeae | |
| Bronchial washings; Bronchoalveolar lavage; Nasopharyngeal aspirate; Sputum; Sterile site | Legionella longbeachae; Legionella pneumophila | |
| Cerebrospinal fluid (CSF) | Treponema pallidum | |
| Cervical specimen; Genital swabs; Rectal swabs; Urine | Neisseria gonorrhoeae | |
| Cervical specimen; Urine; Vaginal swabs | Neisseria gonorrhoeae | |
| Cervical swabs; Urethral swabs; Urine; Vaginal swabs | Chlamydia trachomatis; Mycoplasma genitalium; Mycoplasma hominis; Neisseria gonorrhoeae; Trichomonas vaginalis; Ureaplasma parvum; Ureaplasma urealyticum | |
| Cervical swabs; Urine; Vaginal swabs | Chlamydia trachomatis; Mycoplasma genitalium; Neisseria gonorrhoeae | |
| Faeces; Tissues | Aeromonas spp.; Campylobacter spp.; Clostridium difficile toxin B; Escherichia coli - Enteroinvasive (EIEC); Salmonella spp.; Shigella spp.; Vibrio spp.; Yersinia enterocolitica | |
| Fluids; Genital swabs; Nasopharyngeal swabs; Rectal swabs; Tissues; Urethral swabs | Neisseria gonorrhoeae | |
| Genital swabs; Tissues; Urine | Fluoroquinolone resistant Mycoplasma genitalium | |
| Genital swabs; Urine | Mycoplasma genitalium | |
| Plasma; Serum; Urine | Leptospira spp. | |
| Tissues | Legionella longbeachae; Legionella pneumophila; Treponema pallidum | |
| Vaginal swabs | Gardnerella vaginalis | |
| Wound swabs | Treponema pallidum | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (fungi) | Bronchial washings; Bronchoalveolar lavage | Aspergillus spp. |
| Bronchial washings; Bronchoalveolar lavage; Sputum; Tissues | Pneumocystis jirovecii | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (helminth parasites) | Faeces | Ancylostoma duodenale; Ascaris spp. (roundworm); Enterobius vermicularis; Hymenolepis diminuta; Hymenolepis nana; Necator americanus; Strongyloides stercoralis; Taenia multiceps; Taenia saginata; Taenia solium; Trichuris trichiura |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Blood | Plasmodium falciparum; Plasmodium knowlesi; Plasmodium malariae; Plasmodium ovale curtisi; Plasmodium ovale wallikeri; Plasmodium vivax |
| Cervical swabs; Urine; Vaginal swabs | Trichomonas vaginalis | |
| FaecesBowel tissue | Blastocystis hominis; Cryptosporidium spp.; Cyclospora cayetanensis; Dientamoeba fragilis; Entamoeba histolytica; Giardia lamblia | |
| Genital swabs; Urine | Trichomonas vaginalis | |
| Microbiology - Mycobacteriology - Tests for antigen lymphocyte stimulation | Blood | Mycobacterial antigen lymphocyte stimulation |
| Microbiology - Mycology - Detection of dermatophytes and other fungi causing cutaneous disease | Nails; Skin scrapings | Dermatophyte identification |
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Bronchial lavage; Serum | Isolation of yeasts and Aspergillus |
| Cerebrospinal fluid (CSF); Serum | Cryptococcus antigen | |
| Isolates | Fungi susceptibility; Yeast susceptibility | |
| Nails; Skin scrapings | Fungi identification | |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Microfilaria; Malaria |
| Microfilaria; Malaria | ||
| Eye swabs; Faeces; Sputum; Tissues; Urine | Microsporidia | |
| Faeces | Parasites | |
| Cryptosporidia | ||
| Semen; Urine | Ova | |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Urine | Legionella pneumophila serogroup 1 antibody |
Blood Borne Viruses
ISO 15189 (2012)
Human Pathology
Medicare expiry date
31 Oct 2026
Last Activity Date
10 May 2023
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Blood | Human T-lymphotropic virus type II (HTLV-II); Human T-lymphotropic virus type I (HTLV-I); Human immunodeficiency virus (HIV) DNA; Human immunodeficiency virus type 2 (HIV-2) DNA |
| Blood; Cerebrospinal fluid (CSF); Plasma; Serum | Human immunodeficiency virus type 1 (HIV-1) RNA | |
| Blood; Cerebrospinal fluid (CSF); Plasma; Serum; Tissues; Urine | BK virus | |
| Blood; Cerebrospinal fluid (CSF); Serum; Tissues; Urine | John Cunningham virus (JC) | |
| Blood; Cerebrospinal fluid (CSF); Urine | BK virus | |
| John Cunningham virus (JC) | ||
| Blood; Plasma | Human immunodeficiency virus type 2 (HIV-2) RNA | |
| Human immunodeficiency virus type 1 (HIV-1) RNA | ||
| Human immunodeficiency virus type 1 (HIV-1) RNA | ||
| Blood; PlasmaPlasma (ACD and EDTA) | Human immunodeficiency virus type 1 (HIV-1) RNAChange to Human immunodeficiency virus type 1 (HIV-1) RNA qualitative NAAT and viral load | |
| Blood; Serum | Hepatitis E virus (HEV) | |
| Hepatitis B virus (HBV) DNA; Hepatitis C virus (HCV) viral RNA | ||
| Hepatitis B virus (HBV) DNA | ||
| Hepatitis D virus (HDV) | ||
| Hepatitis A virus (HAV) | ||
| Blood; Serum; Tissues | Hepatitis A virus (HAV); Hepatitis E virus (HEV) | |
| Blood; Urine | John Cunningham virus (JC) | |
| Cerebrospinal fluid (CSF); Serum | Human immunodeficiency virus type 1 (HIV-1) RNA | |
| Plasma; Serum | Hepatitis C virus (HCV) sequencing for antiviral resistance | |
| Hepatitis B virus (HBV) DNA | ||
| Hepatitis B virus (HBV) DNA; Hepatitis C virus (HCV) viral RNA | ||
| Microbiology - Molecular biology - Microbial genotyping | Blood | Human immunodeficiency virus type 1 (HIV-1) proviral DNA |
| Blood; Cerebrospinal fluid (CSF); Plasma; Serum | Human immunodeficiency virus (HIV) co-receptor tropism genotype; Human immunodeficiency virus type 1 (HIV-1) sequencing for drug resistance | |
| Blood; Plasma | Human immunodeficiency virus type 1 (HIV-1) sequencing for drug resistance | |
| Plasma | Human immunodeficiency virus type 1 (HIV-1) sequencing for drug resistance | |
| Plasma; Serum | Hepatitis C virus (HCV) subtypes | |
| Serum | Hepatitis C virus (HCV) subtypes | |
| Microbiology - Molecular biology - Quantitation of microbial nucleic acids | Blood | Human T-lymphotropic virus (HTLV) viral load |
| Blood; Plasma | Human immunodeficiency virus (HIV) RNA viral load | |
| Human immunodeficiency virus (HIV) RNA viral load | ||
| Cerebrospinal fluid (CSF); Serum | Human immunodeficiency virus (HIV) RNA viral load | |
| Plasma | Human immunodeficiency virus (HIV) RNA viral load |
Enteric Viruses Reference Laboratory
ISO 15189 (2012)
Human Pathology
Medicare expiry date
31 Oct 2026
Last Activity Date
10 May 2023
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Faeces; General swabs; Isolates; Nucleic acid | Enterovirus |
| Enterovirus | ||
| Faeces; Isolates; Nucleic acid | Poliovirus | |
| Isolates | Poliovirus | |
| Microbiology - Molecular biology - Microbial genotyping | Faeces; Nucleic acid; Vomitus | Norovirus |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Blood; Plasma; Serum | Poliovirus type 1/2/3 |
| Microbiology - Virology - Detection of pathogenic viruses | Faeces; General swabs; Isolates | Enterovirus |
Mycobacterium Reference Laboratory (MRL)
ISO 15189 (2012)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
31 Oct 2026
Last Activity Date
10 May 2023
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (mycobacteria) | Ascitic fluid; Aspirates; Bacterial isolates; Cerebrospinal fluid (CSF); Gastrointestinal fluid; Lymph node fluid; Nasopharyngeal aspirate; Paraffin embedded tissue; Pericardial fluid; Peritoneal fluid; Pleural fluid; Pus; Respiratory specimens; Tissues | Mycobacterium tuberculosis complex; Mycobacterium rifampicin resistance rpoB |
| Ascitic fluid; Aspirates; Blood; Bone marrow; Cerebrospinal fluid (CSF); Faeces; Gastrointestinal fluid; General swabs; Lymph node fluid; Nasopharyngeal aspirate; Paraffin embedded tissue; Pericardial fluid; Peritoneal fluid; Pleural fluid; Pus; Respiratory specimens; Tissues | Mycobacterium tuberculosis complex | |
| Ascitic fluid; Aspirates; Blood; Bone marrow; Cerebrospinal fluid (CSF); Gastrointestinal fluid; General swabs; Lymph node fluid; Nasopharyngeal aspirate; Paraffin embedded tissue; Pericardial fluid; Peritoneal fluid; Pleural fluid; Pus; Respiratory specimens; Tissues | Mycobacterium spp. | |
| Aspirates; Blood; Bronchial washings; Bronchoalveolar lavage; Cerebrospinal fluid (CSF); Paraffin embedded tissue; Respiratory specimens; Tissues | Mycobacterium tuberculosis complex | |
| General swabs; Nasal secretions; Paraffin embedded tissue; Pus; Respiratory specimens; Skin scrapings; Tissues | Mycobacterium leprae | |
| General swabs; Paraffin embedded tissue; Tissues | Mycobacterium ulcerans | |
| Isolates | Mycobacterium avium complex (MAC) | |
| Sputum | Mycobacterium tuberculosis complex; Mycobacterium rifampicin resistance rpoB | |
| Microbiology - Molecular biology - Microbial genotyping | Aspirates; Blood; Bronchial washings; Bronchoalveolar lavage; Cerebrospinal fluid (CSF); Fluids; Paraffin embedded tissue; Tissues | Drug resistance Mycobacterium tuberculosis |
| Sputum | Drug resistance Mycobacterium tuberculosis | |
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Ascitic fluid; Aspirates; Bone marrow; Faeces; Gastrointestinal fluid; Lymph node fluid; Other body fluids; Pericardial fluid; Peritoneal fluid; Pus; Respiratory specimens; Tissues | Mycobacteria detection |
| Mycobacteria detection | ||
| Blood; Bone marrow | Mycobacteria detection | |
| Isolates | Mycobacterium tuberculosis complex antigen | |
| Mycobacteria identification |
Serology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
31 Oct 2026
Last Activity Date
10 May 2023
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Cadaveric blood | Hepatitis B virus surface antigen (HBs Ag); Hepatitis B virus surface antigen (HBs Ag) - Confirmatory; Hepatitis B virus surface antigen (HBs Ag) neutralisation |
| Hepatitis C virus antibody (anti-HCV) | ||
| Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Human immunodeficiency virus type 1/2 (HIV-1/2) antigen | ||
| Cerebrospinal fluid (CSF) | Human immunodeficiency virus (HIV) | |
| Measles IgG antibody; Measles IgM antibody | ||
| Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Human immunodeficiency virus type 1/2 (HIV-1/2) antigen | ||
| Japanese encephalitis virus (JEV) | ||
| Syphilis Treponema pallidum total antibody | ||
| Syphilis Treponema pallidum IgM antibody | ||
| Syphilis Treponema pallidum antibody | ||
| Cerebrospinal fluid (CSF); Serum | Murray Valley encephalitis virus | |
| Plasma; Serum | Hepatitis B virus core antibody (anti-HBc) - IgM | |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) antibody | ||
| Syphilis Treponema pallidum antibody | ||
| Mumps virus IgG antibody; Mumps virus IgM antibody | ||
| Herpes simplex virus (HSV) IgG; Herpes simplex virus (HSV) IgM | ||
| Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Human immunodeficiency virus type 1/2 (HIV-1/2) antigen | ||
| Human T-lymphotropic virus type I/II (HTLV-I/II) | ||
| Brucella abortus IgG antibody; Brucella abortus IgM antibody; Syphilis Treponema pallidum IgM antibody | ||
| Dengue virus NS1 antigen | ||
| Taenia solium | ||
| Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus envelope antibody (anti-HBe); Hepatitis B virus envelope antigen (HBe Ag); Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag) | ||
| Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis A virus antibody (anti-HAV) - Total | ||
| Hepatitis B virus surface antigen (HBs Ag) | ||
| Herpes simplex virus type 2 antibody (anti-HSV2) - IgG; Herpes simplex type 1 antibody (anti-HSV1) - IgG | ||
| Hepatitis C virus antibody (anti-HCV) - Total | ||
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike Total antibody | ||
| Entamoeba histolytica IgG antibody; Parvovirus B19 IgG antibody; Parvovirus B19 IgM antibody | ||
| Hepatitis C virus antibody (anti-HCV) | ||
| Human T-lymphotropic virus type I/II (HTLV-I/II) | ||
| Cytomegalovirus (CMV) IgG avidity; Cytomegalovirus antibody (anti-CMV) IgG; Cytomegalovirus antibody (anti-CMV) IgM; Epstein-Barr virus nuclear antigen IgG antibody; Epstein-Barr virus viral capsid antigen IgG antibody; Epstein-Barr virus viral capsid antigen IgM antibody; Human immunodeficiency virus (HIV); Measles IgG antibody; Measles IgM antibody | ||
| Hepatitis C virus antibody (anti-HCV) - Total | ||
| Measles virus IgG avidity | ||
| Hepatitis E virus (HEV) IgG | ||
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid Total antibody | ||
| Dengue virus IgG antibody; Dengue virus IgM antibody | ||
| Human immunodeficiency virus (HIV) | ||
| Measles IgG antibody; Measles IgM antibody; Rubella IgG antibody; Rubella IgM antibody; Zika virus IgG antibody; Zika virus IgM antibody | ||
| Serum | Japanese encephalitis virus (JEV); Toxoplasma spp. IgG antibody; Toxoplasma spp. IgM antibody | |
| Strongyloides IgG antibody | ||
| Ross River virus IgG antibody; Ross River virus IgM antibody | ||
| Legionella spp. | ||
| Kunjin virus | ||
| Barmah forest virus IgG antibody; Barmah forest virus IgM antibody | ||
| Coxiella burnetii (Q-fever) IgG phase 2 antibody | ||
| Echinococcus granulosus total antibody | ||
| Mycoplasma total antibody | ||
| Rubella IgG antibody; Rubella IgM antibody | ||
| Chlamydial spp. IgG antibody; Chlamydial spp. IgG antigen | ||
| Chikungunya virus IgG antibody; Chikungunya virus IgM antibody; Hantavirus IgG; Hantavirus IgM | ||
| Japanese encephalitis virus (JEV) IgG antibody; Japanese encephalitis virus (JEV) IgM antibody | ||
| Coronavirus SARS | ||
| Schistosoma mansoni total antibody | ||
| Hepatitis D virus (HDV) | ||
| Syphilis Treponema pallidum total antibody | ||
| Yellow fever virus | ||
| Human herpes virus type 6 (HHV6) IgG antibody; Human herpes virus type 6 (HHV6) IgM antibody | ||
| Japanese encephalitis virus (JEV) total antibody | ||
| Rubella IgM antibody |
Virus Identification
ISO 15189 (2012)
Human Pathology
Medicare expiry date
31 Oct 2026
Last Activity Date
10 May 2023
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Aspirates; Bacterial isolates; Blood; Bone marrow; Bronchial washings; Bronchoalveolar lavage; Brushings; Cerebrospinal fluid (CSF); Faeces; Fluids; Fresh biopsy; General swabs; Human breast milk; Intestinal contents; Lavage; Nucleic acid; Paraffin embedded tissue; Plasma; Saliva; Scrapings; Semen; Serum; Sputum; Tissues; Urine | Chlamydophila psittaci |
| Mycoplasma pneumoniae | ||
| Chlamydophila pneumoniae | ||
| Bordetella pertussis | ||
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Aspirates; Blood; Bone marrow; Bronchial washings; Bronchoalveolar lavage; Brushings; Cerebrospinal fluid (CSF); Faeces; Fluids; Fresh biopsy; General swabs; Human breast milk; Intestinal contents; Isolates; Lavage; Nucleic acid; Plasma; Saliva; Scrapings; Semen; Serum; Sputum; Tissues; Urine | Toxoplasma gondii |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | 3D printed swabs; Flocked saliva swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
| Aspirates; Blood; Bone marrow; Bronchial lavage; Bronchial washings; Bronchoalveolar lavage; Brushings; Cerebrospinal fluid (CSF); Faeces; Fluids; Fresh biopsy; General swabs; Human breast milk; Intestinal contents; Isolates; Lavage; Nucleic acid; Paraffin embedded tissue; Plasma; Saliva; Scrapings; Semen; Serum; Sputum; Tissues; Urine | Junin virus | |
| Coxsackie virus | ||
| Varicella zoster virus (VZV) - Vaccine strain | ||
| Hendra virus | ||
| Echovirus | ||
| Hantavirus | ||
| Alphavirus | ||
| Lymphocytic choriomeningitis virus | ||
| Parainfluenza virus type 1/2/3 | ||
| Monkeypox virus | ||
| Guanarito virus | ||
| Respiratory syncytial virus (RSV) | ||
| Influenza A virus typing | ||
| Human herpes virus type 6 (HHV6) | ||
| Epstein-Barr virus | ||
| Tanapox virus | ||
| Ebola virus | ||
| Cowpox virus; Cytomegalovirus (CMV); Monkeypox virus; Orthopox virus group; Parapox virus; Smallpox virus; Yatapox virus | ||
| Human herpes virus type 7 (HHV7) | ||
| Monkeypox virus; Orthopox virus group; Smallpox virus | ||
| Chikungunya virus - Mauritius strain | ||
| Cytomegalovirus (CMV); Herpes simplex virus type 1 (HSV1); Herpes simplex virus type 2 (HSV2); Varicella zoster virus (VZV) | ||
| Toscana virus | ||
| Human parechovirus | ||
| Rabies virus genus | ||
| Herpes simplex virus (HSV) phenotyping | ||
| Measles virus | ||
| Epstein-Barr virus - Quantitative | ||
| Crimean-Congo hemorrhagic fever virus (CCHF) | ||
| Marburg virus | ||
| Alphavirus | ||
| Flavivirus | ||
| Kunjin virus | ||
| Japanese encephalitis virus (JEV) | ||
| Enterovirus | ||
| Sindbis virus | ||
| Middle Eastern respiratory syndrome coronavirus (MERS-CoV) | ||
| Sabia virus | ||
| Cytomegalovirus (CMV) sequencing | ||
| Coronavirus SARS | ||
| Nipah virus | ||
| Rubella virus | ||
| Cytomegalovirus (CMV) - Quantitative | ||
| Herpesvirus simiae (Herpes virus B) | ||
| Adenovirus | ||
| Cowpox virus | ||
| Coronavirus | ||
| Dengue virus | ||
| Lassa virus | ||
| Picornavirus | ||
| Cytomegalovirus (CMV) | ||
| Rift Valley fever virus | ||
| Varicella zoster virus (VZV) | ||
| Parvovirus B19 | ||
| Rabies virus | ||
| Molluscum contagiosum virus | ||
| Human herpes virus type 8 (HHV8) | ||
| Orf virus; Parapox virus | ||
| Influenza A virus | ||
| Human metapneumovirus | ||
| Yatapox virus | ||
| Mumps virus | ||
| Blood; Cerebrospinal fluid (CSF); Plasma; Serum; Tissues; Urine | Japanese encephalitis virus (JEV) | |
| Faeces; Intestinal contents | Norovirus | |
| Nasal aspirates/washes; Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Oropharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) - PCR, RT-PCR | |
| Nasal aspirates/washes; Nasal swabs; Nasopharyngeal swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) - PCR, RT-PCR | |
| Nasal aspirates/washes; Nasal swabs; Nasopharyngeal swabs; Oropharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Nasal swabs; Nasopharyngeal swabs | Influenza A virus; Influenza B virus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) - PCR, RT-PCR | |
| Nasal swabs; RhinoswabsUnsupervised, self collect | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) - PCR, RT-PCR | |
| Nasopharyngeal swabs | Adenovirus; Human metapneumovirus; Rhinovirus | |
| Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) | ||
| Nasopharyngeal swabs; Oropharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Respiratory swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Vomitus | Norovirus | |
| Microbiology - Molecular biology - Microbial DNA and/or RNA sequencing | Purified PCR product | Sequenced DNA by Sanger sequencing |
| Microbiology - Molecular biology - Microbial genotyping | Aspirates; Blood; Bone marrow; Bronchial lavage; Bronchial washings; Bronchoalveolar lavage; Brushings; Cerebrospinal fluid (CSF); Faeces; Fluids; Fresh biopsy; General swabs; Human breast milk; Intestinal contents; Isolates; Lavage; Nucleic acid; Paraffin embedded tissue; Plasma; Saliva; Scrapings; Semen; Serum; Sputum; Tissues; Urine | Alphavirus |
| Enterovirus | ||
| Aspirates; Blood; Bone marrow; Brushings; Cerebrospinal fluid (CSF); Faeces; Fluids; Fresh biopsy; General swabs; Human breast milk; Intestinal contents; Isolates; Lavage; Nucleic acid; Paraffin embedded tissue; Plasma; Saliva; Scrapings; Semen; Serum; Sputum; Tissues; Urine; Washings | Cytomegalovirus (CMV) | |
| Varicella zoster virus (VZV) genotyping | ||
| Ross River virus | ||
| Yellow fever virus | ||
| Murray Valley encephalitis virus | ||
| Herpes simplex virus (HSV) | ||
| Parechovirus | ||
| Measles virus genotyping | ||
| Measles virus genotyping | ||
| Flavivirus | ||
| Microbiology - Molecular biology - Surveillance programme for the detection of microbial nucleic acids (viruses) in accordance with Commonwealth and/or State Health protocols | Saliva | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
WHOCCRRI
ISO 15189 (2012)
Human Pathology
Medicare expiry date
31 Oct 2026
Last Activity Date
10 May 2023
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Isolates; Nasal swabs; Nasopharyngeal aspirate; Sputum; Throat swabs; Tissues | Influenza A virus; Influenza B virus |
| Isolates; Nasal swabs; Nasopharyngeal aspirate; Throat swabs; Tissues | Influenza A virus; Influenza A virus H1/H; Influenza B virus; Influenza virus H1N1 - Swine | |
| Microbiology - Virology - Public health investigation and/or monitoring | Isolates; Respiratory swabs and/or washings; Tissues | Detection, isolation and characterisation of virusesInfluenza A H3N2 virus |
| Detection, isolation and characterisation of virusesInfluenza A virus; Influenza B virus | ||
| Detection, isolation and characterisation of virusesInfluenza A virus; Influenza B virus | ||
| Detection, isolation and characterisation of virusesInfluenza A virus; Influenza B virus | ||
| Detection, isolation and characterisation of virusesInfluenza A virus; Influenza B virus |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2576
Site No.
2569
Print date
28 Nov 2024
END OF SCOPE